Category: In the Media highlight

VIDEO: Spotlight on NYGC’s Disease-Based Research Focus, Liquid Biopsy, CRISPR, Polyethnic-1000 Initiative, and Single-Cell Analysis Tools

On February 27, 2019, New York Genome Center (NYGC) Scientific Director and CEO Tom Maniatis, PhD, moderated a “NYGC Research Spotlight: The Future of Genomics” event for the MIT Enterprise Forum’s New York chapter, with presentations by NYGC Core Faculty Members Dan Landau, MD, PhD, and Neville Sanjana, PhD, and NYGC staff scientists Nicolas Robine, […]

Dr. Tuuli Lappalainen Receives Prestigious Leena Peltonen Prize for Excellence in Human Genetics

First Finnish genomic researcher to receive award honoring one of Finland’s most renowned scientists  Tuuli Lappalainen, PhD, Core Faculty Member, New York Genome Center (NYGC) and Assistant Professor, Department of Systems Biology, Columbia University, is the recipient of the 2018 Leena Peltonen Prize for Excellence in Human Genetics. The award was presented to Dr. Lappalainen […]

MSK, NYGC Collaborative Study Pinpoints New Cause of Resistance to EGFR-Targeting Drugs

A collaborative study between scientists at Memorial Sloan Kettering Cancer Center and the New York Genome Center has identified one way that lung cancer cells outsmart a common targeted drug therapy. The results, reported June 6, 2018 in the Proceedings of the National Academy of Sciences, pave the way for improved treatments. Read the June […]

NYGC Scientists Contribute to CSHL-Led Organoid Profiling Study Facilitating Personalized Treatments for Pancreatic Cancer

Organoid profiling personalizes treatments for pancreatic cancer They could be used to select the treatments most likely to work in specific patients Patient-derived organoids, hollow spheres of cells cultured from tumors, can quickly and accurately predict how patients with pancreatic cancer respond to a variety of treatments, facilitating a precision-medicine approach to the deadly disease. […]